CD247 and neoplasm: Recently, a new generation of CAR-T cells was designed by encoding a truncated cytoplasmic domain that binds to CD3z and CD28 domains together; the modified CAR-T cells showed better persistence and anti-tumor effects than traditional CAR-T cells (41).